{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:58Z","timestamp":1787004838121,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2003,12,30]],"date-time":"2003-12-30T00:00:00Z","timestamp":1072742400000},"content-version":"vor","delay-in-days":669,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Dorothy Hodgkin Fellow of the Royal Society, London, UK"},{"name":"Children's Liver Disease Foundation, Birmingham, UK"},{"DOI":"10.13039\/501100000290","name":"Children's Liver Disease Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000290","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Children's Liver Disease Foundation and by the Children Nationwide Medical Research Trust"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Prevalence and clinical relevance of antibodies to soluble liver antigen (tRNP\n                      <jats:sup>(Ser)Sec<\/jats:sup>\n                      \/SLA) in autoimmune hepatitis (AIH) have been investigated using partially purified or prokaryotically expressed antigen. The aim of this study was to improve the detection of anti-tRNP\n                      <jats:sup>(Ser)Sec<\/jats:sup>\n                      \/SLA by establishing an immunoassay that was able to identify antibodies directed to conformational epitopes and to investigate the clinical implication of this autoantibody in autoimmune liver disease. By using eukaryotically expressed tRNP\n                      <jats:sup>(Ser)Sec<\/jats:sup>\n                      \/SLA as target in a radioligand assay (RLA), 81 patients with autoimmune liver disease (AILD) (33 type 1 AIH, 31 type 2 AIH, and 17 autoimmune sclerosing cholantitis [ASC]), 147 pathologic, and 56 healthy controls were investigated. RLA results were compared with those obtained using a commercial enzyme-linked immunosorbent assay (ELISA) and immunoblot. Reactivity to tRNP\n                      <jats:sup>(Ser)Sec<\/jats:sup>\n                      \/SLA was present in 58% of patients with type 1 and type 2 AIH, 41% with ASC, but in only 3 pathologic controls. RLA was similarly disease-specific but remarkably more sensitive than ELISA and immunoblot. A prospective study showed that anti-tRNP\n                      <jats:sup>(Ser)Sec<\/jats:sup>\n                      \/SLA-positive patients run a severe clinical course, having worse histology, needing longer to achieve remission, relapsing and requiring liver transplantation or dying more frequently than anti-tRNP\n                      <jats:sup>(Ser)Sec<\/jats:sup>\n                      \/SLA negative patients. Anti-tRNP\n                      <jats:sup>(Ser)Sec<\/jats:sup>\n                      \/SLA production was favored by the possession of DR3 and A1-B8-DR3 in AIH type 1 and ASC, and prevented by the possession of A2 in all 3 types of AILD, particularly in type 2 AIH. In conclusion, anticonformational tRNP\n                      <jats:sup>(Ser)Sec<\/jats:sup>\n                      \/SLA reactivity is frequent in type 1 and type 2 AIH and ASC, defining patients with a worse prognosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1053\/jhep.2002.32092","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T23:46:10Z","timestamp":1030232770000},"page":"658-664","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":227,"title":["Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease"],"prefix":"10.1097","volume":"35","author":[{"given":"Yun","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnel R.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Portmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Underhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"D\u00fcrr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1053\/jhep.2002.32092-BIB1|cit1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review criteria for the diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1053\/jhep.2002.32092-BIB2|cit2","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1073\/pnas.85.21.8256","article-title":"Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II","volume":"85","author":"Zanger","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/jhep.2002.32092-BIB3|cit3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"I","author":"Manns","year":"1987","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.32092-BIB4|cit4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0168-8278(90)90119-C","article-title":"Characterisation of liver cytokeratin as a major target antigen of anti-SLA antibodies","volume":"11","author":"W\u00e4chter","year":"1990","journal-title":"J Hepatol"},{"key":"10.1053\/jhep.2002.32092-BIB5|cit5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0016-5085(98)70485-8","article-title":"Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis","volume":"114","author":"Wesierska-Gadek","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/jhep.2002.32092-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.32092-BIB7|cit7","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","article-title":"Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion","volume":"89","author":"Gelp\u00ed","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/jhep.2002.32092-BIB8|cit8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01280.x","article-title":"Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis","volume":"121","author":"Costa","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/jhep.2002.32092-BIB9|cit9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/jhep.2001.26632","article-title":"A bioinformatical approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigen\/liver pancreas","volume":"34","author":"Kernebeck","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.32092-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840180102","article-title":"Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis","volume":"18","author":"Stechemesser","year":"1993","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.32092-BIB11|cit11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/jhep.2001.22218","article-title":"Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis","volume":"33","author":"Volkmann","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.32092-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.32092-BIB13|cit13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.32092-BIB14|cit14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorgio","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.32092-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.32092-BIB16|cit16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0022-1759(95)00139-2","article-title":"Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD67 autoantibodies using 35S or 3H recombinant human ligands","volume":"186","author":"Falorni","year":"1995","journal-title":"J Immunol Methods"},{"key":"10.1053\/jhep.2002.32092-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0168-8278(97)80477-1","article-title":"Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection","volume":"26","author":"Ma","year":"1997","journal-title":"J Hepatol"},{"issue":"Suppl","key":"10.1053\/jhep.2002.32092-BIB18|cit18","first-page":"190A","article-title":"Cloning of the target antigen of antibodies to soluble liver antigen: identification of a novel 50 kDa protein with two splice-variants [Absract]","volume":"28","author":"Wies","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.32092-BIB19|cit19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1042\/bj0600604","article-title":"Tissue fractionation studies. Intracellular distribution patterns of enzymes in rat liver tissue","volume":"60","author":"De Duve","year":"1955","journal-title":"Biochem J"},{"key":"10.1053\/jhep.2002.32092-BIB20|cit20","first-page":"58","article-title":"Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease","volume":"21","author":"Han","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.32092-BIB21|cit21","first-page":"67","volume-title":"Manual of Tissue Typing Techniques","author":"Terasaki","year":"1974"},{"key":"10.1053\/jhep.2002.32092-BIB22|cit22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.32092-BIB23|cit23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","author":"Kanzler","year":"1999","journal-title":"J Hepatol"},{"key":"10.1053\/jhep.2002.32092-BIB24|cit24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(00)80361-X","article-title":"Antibodies to soluble liver antigen: an additional marker in type 1 autoimmune hepatitis","volume":"33","author":"Ballot","year":"2000","journal-title":"J Hepatol"},{"key":"10.1053\/jhep.2002.32092-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1053%2Fjhep.2002.32092","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1053%2Fjhep.2002.32092","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200203000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:46:45Z","timestamp":1738925205000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200203000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002]]}},"URL":"https:\/\/doi.org\/10.1053\/jhep.2002.32092","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}